Non-Powered Negative Pressure Wound Therapy vs Open Technique for Pilonidal Disease (NPWTvsOT)

April 4, 2019 updated by: Yasir Bashir, The National Children's Hospital, Tallaght

Randomized Controlled Trial of Non-Powered Negative Pressure Wound Therapy vs Open Technique for Pilonidal Disease

Pilonidal Disease is disease of young patients with significant morbidity and is difficult to treat. Currently multiple methods are practiced for the treatment of the disease, two of them are preferred over others and practice extensively. First one involves excision of pilonidal sinus and dressings while the second one is excision of the pilonidal sinus with application of negative pressure wound therapy. None of these approaches is considered superior to the other, as not enough comparison studies of the two procedures have been done. In order to clarify this and find the best option for our patients, investigators are taking opportunity to compare these two modalities. If participants choose to participate in this study they will be randomly selected to one of these groups and the progress of wound healing will be monitored after surgery with the measurement of wound weekly and photographs. Investigators are hoping to find out which procedure is superior. This will allow investigators to provide the best treatment option for their patients in future.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult patient suffering from Pilonidal Disease willing to participate in study.

Exclusion Criteria:

  • Patients below the age of 16 years (not able to consent).
  • Not consenting to participate in study.
  • Patient with less than 3 cm between inferior opening of sinus and anus.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Non powered-NPWT
After excision of pilonidal sinus Non powered-NPWT will be applied to the area
ACTIVE_COMPARATOR: Open Technique
After excision of pilonidal sinus normal dressing will be applied to the area of surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to complete wound healing
Time Frame: Wound will be assessed for healing at 1 week to 6 weeks
Time between Surgery and complete healing when there is no further requirement to apply dressing
Wound will be assessed for healing at 1 week to 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAS score (Visual Analogue Scale)
Time Frame: VAS for pain will be recorded at 1 week to 6 weeks at weekly intervals
Pain score as scored by patients, VAS is an analogue scale is from 1 to 10, 1 being minimal discomfort to 10 being the worst pain in the life
VAS for pain will be recorded at 1 week to 6 weeks at weekly intervals
Wound size ratio
Time Frame: Wound size ratio will be recorded at 1 week to 6 weeks at weekly intervals
Healing as ratio of the initial wound
Wound size ratio will be recorded at 1 week to 6 weeks at weekly intervals
Time to resume daily activities
Time Frame: Assessment will be done at 1 week to 6 weeks at weekly intervals
Time at which patient is able to do his/her daily household works
Assessment will be done at 1 week to 6 weeks at weekly intervals
Recurrence
Time Frame: Patient will be assessed at 6 months from surgery
Recurrence of disease at 6 months from surgery
Patient will be assessed at 6 months from surgery
Analgesia Requirement
Time Frame: Recording will be done at 1 week to 6 weeks at weekly intervals
Requirement for analgesia will be recorded to make the pain analysis more robust
Recording will be done at 1 week to 6 weeks at weekly intervals

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 21, 2018

Primary Completion (ANTICIPATED)

October 30, 2019

Study Completion (ANTICIPATED)

November 30, 2019

Study Registration Dates

First Submitted

March 17, 2018

First Submitted That Met QC Criteria

March 29, 2018

First Posted (ACTUAL)

March 30, 2018

Study Record Updates

Last Update Posted (ACTUAL)

April 5, 2019

Last Update Submitted That Met QC Criteria

April 4, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2018-02

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Time Frame

data will be available on request for 3 months at publication of study

IPD Sharing Access Criteria

Send email to Principal Investigator with query and information needed. Principal Investigator will reply as soon as possible and provide the information requested.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pilonidal Sinus

Clinical Trials on NPWT for Pilonidal Surgery

3
Subscribe